TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
Amycretin is Novo Nordisks GLP-1 and amylin receptor agonist, being developed in both injectable and oral forms
This results in the hair strands turning white and is completely devoid of melanin
In the absence of placebo controlled trials it is not possible to be enthusiastic about this product
When a cell over-expresses NNMT, it does two costly things at once: it burns through methyl-donor capacity, and it diverts nicotinamide away from NAD+ regeneration into an inert metabolite (1-methylnicotinamide) that gets excreted
L.DumitrascuD